AAPG

Ascentage Pharma Group International (AAPG)

About Ascentage Pharma Group International (AAPG)

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Details

Daily high

$18.98

Daily low

$18.31

Price at open

$18.49

52 Week High

$48.45

52 Week Low

$16.36

Market cap

1.6B

Dividend yield

0.00%

Volume

8,680

Avg. volume

5,455

P/E ratio

-8.80

Ascentage Pharma Group International News